The PE Consolidation Playbook for Orthopaedic Groups: What to Fix in Your Revenue Cycle Before You Sell

Before an orthopaedic group enters a private equity transaction, the single highest-leverage work it can do is clean up its revenue cycle, because valuation is driven by EBITDA and a leaking revenue cycle understates the earnings a buyer is willing to pay for.

Fixing coding accuracy, denial rates, and collections before diligence begins does two things at once: it raises current profitability and it demonstrates the operational discipline that commands a premium multiple. The groups that command the strongest terms are not the ones with the most surgeons; they are the ones whose financials are clean, defensible, and clearly scalable.

This playbook covers what PE buyers actually scrutinize in an orthopaedic revenue cycle and the specific fixes that move both your current earnings and your negotiating position.

Why the Revenue Cycle Drives Your Valuation

PE valuations are typically a multiple of adjusted EBITDA, so every dollar of recovered net revenue that falls to the bottom line can be worth several dollars of enterprise value at exit. A group losing revenue to undercoding, high denial rates, or slow collections is effectively selling those losses at a multiple.

Just as important, buyers price risk: a revenue cycle that depends on a few tenured coders, manual processes, and tribal knowledge looks fragile, while one that is systematized and technology-supported looks durable and scalable across future acquisitions.

Fix 1: Close the Undercoding Gap

Undercoding is the most common and most invisible drag on orthopaedic EBITDA. Because undercoded claims still get paid, the loss never appears as a denial or a write-off; it simply never shows up as revenue. A pre-transaction coding audit that quantifies the gap and a system that codes to documented complexity going forward can lift revenue per surgeon measurably, and that lift flows straight into the earnings a buyer values.

Fix 2: Bring Down Your Denial Rate

A high denial rate signals operational weakness to a sophisticated buyer and directly suppresses collected revenue. MGMA benchmarking consistently shows top-performing groups keeping denial rates low and clean claim rates high. Attacking preventable denials, the ones caused by coding and documentation errors, before diligence both improves your reported numbers and removes a line of questioning that buyers use to justify a lower offer.

Fix 3: Tighten AR Days and Collections

Aging accounts receivable ties up cash and raises questions about the collectability of your book. Buyers look closely at AR days, aged buckets, and the consistency of collections. Systematizing follow-up, retro-authorization, and appeals shortens the cash cycle and produces the kind of predictable, well-documented collections history that supports a clean quality-of-earnings review.

Fix 4: Reduce Key-Person Dependency

If your revenue integrity lives in the heads of two senior coders, that is a concentration risk a buyer will discount. Moving coding logic into a consistent, technology-supported process protects institutional knowledge, reduces the impact of turnover, and makes the revenue cycle look like an asset that scales rather than a liability that must be carefully preserved. This is precisely the argument for autonomous coding: it makes accuracy a property of the system rather than of individual employees.

How to Prepare in the 6 to 12 Months Before a Transaction

Start with a baseline audit to quantify undercoding, denial causes, and AR aging. Prioritize the fixes with the fastest EBITDA impact, typically undercoding and preventable denials. Implement systems that make the improvements durable and documented, so the gains survive diligence rather than looking like a one-time scrub.

Finally, assemble the metrics buyers will ask for, revenue per surgeon, clean claim rate, denial rate, and AR days, so you can tell a clear, defensible story about a revenue cycle that is both healthy today and built to scale.

Frequently Asked Questions

How does the revenue cycle affect my practice's valuation?
PE buyers pay a multiple of adjusted EBITDA, so recovered revenue that reaches the bottom line is amplified at exit. A clean, systematized revenue cycle also lowers perceived risk, which supports a higher multiple.

What should I fix first before a PE transaction?
Start with undercoding and preventable denials, because they have the fastest, most direct impact on EBITDA. Then tighten AR days and reduce dependence on individual coders.

How far in advance should I prepare?
Ideally 6 to 12 months. That gives you time to baseline, implement fixes, and generate a clean track record that survives a quality-of-earnings review rather than looking like a last-minute scrub.

Why do buyers care about coder turnover?
Because revenue integrity concentrated in a few people is a risk. If those coders leave, accuracy drops. Systematized, technology-supported coding makes accuracy durable and scalable, which buyers value.

What metrics will a PE buyer ask for?
Expect scrutiny of revenue per surgeon, clean claim rate, denial rate, AR days and aging buckets, and payer mix. Having these clean and trending in the right direction strengthens your position.

The Bottom Line

Consolidation rewards operational discipline. The orthopaedic groups that fix their revenue cycle before diligence do not just present better numbers; they prove they run a scalable business, and that is what earns a premium.

See how Maia's RCM tools are purpose built for orthopaedic practices. Book a demo at usemaia.com.